Phost’in Therapeutics strengthens management with appointment of veteran lifescience executives Dr. Alain Herrera and Pr. Bernard Pau

Montpellier, France – June 2020, 17th

Phost’in Therapeutics (Montpellier, France), a biopharmaceutical company focused on the discovery and development of N-glycosylation inhibitors, today announced the appointments of Dr. Alain Herrera, MD, PhD as Chief Medical Officer and Pr. Bernard Pau, PhD, as Chief Operating Officer.
Pr. Bernard Pau will also serve as Chairman of the Board.